ELOX

10.6900.38%
SA

Sumit Aggarwal

President, CEO & Director

Mr. Sumit Aggarwal, MBA is Chief Executive officer of Endolytix Technology, Inc. Mr. Aggarwal serves as a Director at Eloxx Pharmaceuticals, Inc. since April 01, 2021. He joined as President and Chief Executive Officer of Eloxx Pharmaceuticals, Inc. from April 01, 2021. He served as President, Chief Executive Officer, Treasurer and Director of Zikani Therapeutics, Inc. from 2019 to April 2021 and served as its Secretary. Mr. Aggarwal joined Zikani in 2018 as Chief Financial Officer and Chief Business Officer and led the transformation of Zikani from an early-stage technology company to a rare disease and oncology-focused organization. Prior to joining Zikani, from 2015 to 2018, Mr. Aggarwal served as acting President and Chief Financial Officer of Progenity, Inc., a private genetic services company offering pre-natal genetic testing to OB/GYN practices. From 2016 to 2018, Mr. Aggarwal served as a member of the board of directors of NEOSEQ, a privately-held genetic sequencing-based diagnostic company. Mr. Aggarwal has also held leadership roles in healthcare and biotechnology at Adage Capital and as an Associate Partner at McKinsey & Company in its healthcare practice. Under Mr. Aggarwal’s leadership, Zikani has concentrated its focus on demonstrating pre-clinical proof of efficacy across several disease states using its TURBO-ZM™ technology platform. In his Tenure in pharmaceutical and biotechnology commercial operations, investment management and management consulting, Mr. Aggarwal was successful in transforming companies by re-invigorating innovation, growth and profitability and raising capital for promising technology companies. Prior to joining Zikani, he reinvigorated growth and profitability at Progenity, built a novel drug delivery-based GI pipeline. He also held leadership roles in healthcare and biotechnology at Adage Capital and as an Associate Partner at McKinsey & Company in its healthcare practice. Mr. Aggarwal has an MBA with distinction from the Johnson School, Cornell University and a Bachelor of Technology with Honors in Chemical Engineering from the Indian Institute of Technology, Kharagpur.

Positions